Skip to content

Effects of Probiotics on Cognition and Health

The Effects of Probiotics on Behavioral and Biological Markers of Cognition and Stress

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02849275
Acronym
EPOCH
Enrollment
24
Registered
2016-07-29
Start date
2016-08-31
Completion date
2018-09-30
Last updated
2018-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiological Stress, Cognition - Other

Brief summary

This research intervention aims to examine the effects of a fermented dairy beverage on changes in behavioral and biological measures of cognition and stress among adults.

Detailed description

Evidence-based dietary strategies provide behavioral means benefiting physical and cognitive function. Pertinent to the proposed work, dietary intake has been recently shown to have the potential to directly influence the gut microbiota composition as well as brain function. Specifically, the consumption of probiotics or foods containing healthful microbial cultures (e.g., fermented milk, yogurts, etc.) are increasingly being recognized as modulators of metabolism, cognition, and stress. These foods are readily available in the marketplace, however, their implications for physical and cognitive function are not clear. Accordingly, the proposed study aims to investigate effects of probiotic beverage consumption on changes in behavioral and biological measures of cognition and stress among adults.

Interventions

isocaloric study treatment containing lactose free 1% milk consumed once daily over 4-5 weeks as a control.

Probiotic treatment, consumed once daily, over 4-5 weeks.

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Participants will pass through 2 arms, control and probiotic, in a randomized, counter-balanced order.

Eligibility

Sex/Gender
ALL
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Males and females * Between the ages of 25-45 years at the time of consent * BMI ≥18.5 kg/m2 * Normal or corrected-to-normal vision based on the minimal 20/20 standard in order to complete the cognitive task. * Ability to drop-off fecal sample within 15 minutes of defecation

Exclusion criteria

* Current pregnancy or lactation * Tobacco use * Dairy allergy or intolerance * Prior diagnosis of metabolic and gastrointestinal disease (cardiovascular disease and type 1 or type 2 diabetes, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers, hepatitis, HIV, cancer, etc.) * Prior diagnosis of cognitive or physical disability, including ADHD, severe asthma, epilepsy, chronic kidney disease * Use of any anti-psychotic, anti-depressant, anti-anxiety, or ADD/ADHD medications * Use of medications that alter normal bowel function and metabolism (e.g., recent antibiotic use, laxatives, enemas, anti-diarrheal agents, narcotics, antacids, antispasmodics, diuretics, anticonvulsants). * Prior malabsorptive bariatric surgery (i.e. gastric bypass, sleeve gastrectomy) or restrictive bariatric surgery (i.e. adjustable gastric band) within the past 2 years.

Design outcomes

Primary

MeasureTime frameDescription
Changes in cortisol as a biomarker of stress4-5 weeksThe effects of probiotic consumption on biomarkers of stress

Secondary

MeasureTime frameDescription
Changes in fecal microbiota populations4-5 weeksThe effects of probiotic consumption on fecal microbiota

Other

MeasureTime frameDescription
Changes in cognition4-5 weeksThe effects of probioticconsumption on cognition

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026